Repository logo
 

High-Definition Analysis of Host Protein Stability during Human Cytomegalovirus Infection Reveals Antiviral Factors and Viral Evasion Mechanisms.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Ravenhill, Benjamin J 
Davies, Colin 
Nobre, Luis 

Abstract

Human cytomegalovirus (HCMV) is an important pathogen with multiple immune evasion strategies, including virally facilitated degradation of host antiviral restriction factors. Here, we describe a multiplexed approach to discover proteins with innate immune function on the basis of active degradation by the proteasome or lysosome during early-phase HCMV infection. Using three orthogonal proteomic/transcriptomic screens to quantify protein degradation, with high confidence we identified 35 proteins enriched in antiviral restriction factors. A final screen employed a comprehensive panel of viral mutants to predict viral genes that target >250 human proteins. This approach revealed that helicase-like transcription factor (HLTF), a DNA helicase important in DNA repair, potently inhibits early viral gene expression but is rapidly degraded during infection. The functionally unknown HCMV protein UL145 facilitates HLTF degradation by recruiting the Cullin4 E3 ligase complex. Our approach and data will enable further identifications of innate pathways targeted by HCMV and other viruses.

Description

Keywords

host-pathogen interaction, immune evasion, innate immunity, lysosome, proteasome, protein degradation, pulsed SILAC, quantitative proteomics, restriction factor, tandem mass tag, Cytomegalovirus, Cytomegalovirus Infections, DNA-Binding Proteins, Humans, Immune Evasion, Protein Stability, Proteins, Proteomics, Transcription Factors, Viral Proteins

Journal Title

Cell Host Microbe

Conference Name

Journal ISSN

1931-3128
1934-6069

Volume Title

24

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (108070/Z/15/Z)
Wellcome Trust (100140/Z/12/Z)
This work was supported by a Wellcome Trust Senior Clinical Research Fellowship (108070) to MPW, a strategic award to Cambridge Institute for Medical Research from the Wellcome Trust (100140), MRC Project Grants to GWGW, PT, ECYW and RJS (MR/L018373/1, MR/P001602/1), a Wellcome Trust Programme Grant (WT090323MA) to GWGW, ECYW and PT, and an MRC Programme Grant (MC_UU_12014/3) to AJD. This study was additionally supported by the Cambridge Biomedical Research Centre, UK.